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Background: Galla Rhois has been considered to have medicinal properties against diarrhea,
excessive sweating, bleeding, and chronic cough in Asian countries. Gallotannins, which are
Galla Rhois-derived tannins, have been reported to possess biological and pharmacological
activities, especially anticancer activity. In this study, we evaluated the effect of steaming
at  a temperature over 120 ◦C on the chemical constituents and biological activities of the
water extract of Galla Rhois (GRE).
Methods: GRE was steamed at a temperature over 120 ◦C (AGRE), and its speciﬁc con-
stituents were analyzed; the results were validated using a high-performance liquid
chromatography–diode array detector system. To evaluate the anticancer effect of GRE and
AGRE, cell viability assay, cell cycle analysis, and Western blot analysis were performed in
HCT116 human colon cancer cells.
Results: Steaming markedly increased the contents of gallic acid and ellagic acid in GRE,
and  GRE or AGRE treatment reduced the viability of HCT116 cells. Notably, the steaming
process enhanced the growth inhibitory effect of GRE in cancer cells. AGRE induced apoptosis
through the activation of caspase-3, caspase-8, and caspase-9. Additionally, AGRE regulated
the  activation of mitogen-activated protein kinases including extracellular signal-regulated
kinase, p38, and c-Jun NH2-terminal kinase, whereas GRE did not. However, both GRE and
AGRE inhibited the activation of AKT.
Conclusion: Compared with GRE, AGRE is more potent in its ability to induce apoptosis inHCT116 cells; therefore, we suggest that the steaming process may be useful as a feasible
method for improving the anticancer effect of GRE.
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.  Introduction
n oriental medicine, various processing methods have been
pplied to herbal medicines in order to improve their ther-
peutic effects in clinical trials. The processing methods
or herbal medicines (such as toasting, steaming, boiling in
oney, and dipping or soaking in water, alcohol, or vine-
ar) can enhance their desirable effect, and reduce side
ffects and toxicity.1 Studies investigating changes in chemi-
al constituents and biological activities upon processing have
een carried out for several herbal medicines, including Rei
hizoma, Glycyrrhizae Radix, Gardeniae Fructus, Zingiberis
iccatum Rhizoma, Lacca Sinica Exsiccata, Machili Cortex, and
ehmanniae Radix.2–7 In this respect, we applied the steaming
rocess to the water extract of Galla Rhois (GRE) at a tempera-
ure over 120 ◦C (AGRE) and identiﬁed the associated changes
n its chemical constituents and biological efﬁcacy.
Galla Rhois (GR), the gall produced by the aphid Schlechren-
alia chineneis (Bell), on the leaves of Rhus chinensis, has been
sed as a traditional medicine for treating diarrhea, exces-
ive sweating, bleeding, and chronic coughs in Korea, China,
nd Japan.8,9 Recent studies have reported the biological
nd pharmacological properties of GR, including antibacterial,
nticariogenic, antioxidant, anticancer, antidiabetic, antidiar-
heal, anti-inﬂammatory, and hepatoprotective activities.10
urthermore, a phytochemical study on GR reported the
haracterization of gallotannin, which consists of gallic acid
nits.11,12 Bioactive gallotannins isolated from GR, includ-
ng pentagalloyl glucose, 3- and 4-galloyl-gallic acid, and
,2,3,4,6-penta-O-galloyl--D-glucoside (PGG), possess numer-
us medicinal activities and health beneﬁts, particularly
nticancer activities.13–15
In the present study, we evaluated the change in GR-derived
annins upon applying a steaming method to GRE using high-
erformance liquid chromatography (HPLC), which showed
hat the steaming process markedly enhances cell death,
specially in colon cancer cells, by increasing the apoptotic
roperties of GRE.
.  Methods
.1.  HPLC  analysis
.1.1.  Chemicals  and  reagents
he standard compound of gallic acid was purchased from TCI
Tokyo, Japan), and methyl gallate, syringic acid, and penta-
-galloyl--D-glucoside were purchased from Sigma-Aldrich
St. Louis, MO, USA). The purity of marker compound deter-
ined using HPLC was higher than 98%. HPLC-grade solutions
ncluding water and acetonitrile were purchased from J.T.
aker (Austin, TX, USA), and triﬂuoroacetic acid was pur-
hased from Sigma-Aldrich.
.1.2.  Preparation  of  standard  solution,  and  herb
aterials  GRE  and  AGRE
tandard solutions, including gallic acid, methyl gallate, digal-
ic acid, syringic acid, ellagic acid, and PGG, were prepared
y dissolving each marker component in pure methanol athois in Human Colon Cancer Cells 285
1 mg/mL  (Fig. 1A). These stock solutions were stored at −4 ◦C
before analysis. Each stock solution was diluted to an appro-
priate concentration range for the preparation of calibration
curves. GR was purchased from the Korea Medicine Herbs
Association (Yeongcheon, Korea) and identiﬁed by Professor
KiHwan Bae, Chungnam National University, Korea. GRE was
prepared using GR with water boiling for 3 hours, as described
in a previous study.16 To prepare the AGRE, GRE was steamed
by autoclave (Jeio Tech Co., Daejeon, Korea) treatment (120 ◦C,
20 minutes) and prepared in the form of powder by freeze
drying. For HPLC analysis, 1 mg  of GRE or AGRE powder was
dissolved in 1 mL of distilled water, passed through a 0.22 m
ﬁlter, and stored at −20 ◦C before use.
2.1.3.  HPLC–diode  array  UV/VIS  detector  analysis
conditions
The experiments in this study were performed using the
Hitachi HPLC system (Hitachi, Tokyo, Japan), obtained using
the L-2130 pump, L-2200 auto-sampler, L-2300 column oven,
and L-2455 diode array UV/VIS (ultraviolet/visible) detector.
The data processor used EZchrom Elite software for Hitachi.
The chromatographic column that was used in this exper-
iment was commercially available and was obtained from
Optimapak (C18, 4.6 × 250 mm2, 5 m).  The column oven tem-
perature was kept at 30 ◦C. The mobile phase consisted of
water containing 0.2% triﬂuoroacetic acid (A) and acetonitrile
containing 0.2% triﬂuoroacetic acid (B). The line program was
well optimized and conducted as follow: 5% B at 0–20 minutes;
20–45% B at 20–45 minutes; 45–90% B at 45–90 minutes at a ﬂow
rate of 1.0 mL/min. The UV spectrum was recorded at 270 nm,
and the injection volume was set at 10 L. Components were
identiﬁed via comparison of their retention times with those
of authentic standards under identical analysis conditions and
UV spectra with an in-house PDA (patron-driven acquisition)
library.
2.1.4.  Validation  of  the  analytical  method
The method was validated for linearity, precision and accu-
racy. Validation was executed according to the International
Conference on Harmonization guidelines.17
2.1.5.  Linearity,  limits  of  detection,  and  limits  of
quantiﬁcation
In order to obtain the calibration curves, working solutions
of six different concentrations of each marker compound
were prepared from the stock solutions by diluting with
60% methanol. Solutions of six different concentrations were
analyzed in three consecutive injections. Calibration curves
were constructed by plotting the value of the peak versus
the concentration of each analyte. Limits of detection and
limits of quantiﬁcation for each analyte were determined
on the basis of the signal-to-noise ratios of 3 and 10,
respectively.
2.1.6.  Precision  and  accuracy
Precision of the analytical method was evaluated by intra-
and interday tests. The mixture standard solutions of three
different concentrations were analyzed. The interday test
was performed by analyzing the same standard solution in
ﬁve replicates each day on 3 consecutive days. The intraday
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Fig. 1 – HPLC–DAD analysis of six constituents in GRE and AGRE. (A) Chemical structures of six constituents: 1, gallic acid; 2,
methyl gallate; 3, digallic acid; 4, syringic acid; 5, ellagic acid; and 6, PGG. (B) HPLC–DAD analyses of the six components in
GRE and AGRE at 270 nm:  (a) mixed  standards, (b) GRE, and (c) AGRE. (C) Contents of six components in GRE and AGRE: 1,
 5, egallic acid; 2, methyl gallate; 3, digallic acid; 4, syringic acid;
test was determined by analyzing a mixed standard solu-
tion in ﬁve replicates during 1 day. Precision was expressed
as relative standard deviation (RSD, %); the value of RSD
within 3% is generally acceptable. The related equation was
as follows: RSD (%) = [standard deviation (SD)/mean measured
amount] × 100. The recovery test was conducted to evalu-
ate the accuracy of the method. Recoveries were determined
by adding three different concentrations of each standard
solution into the GRE or AGRE sample solution (20 mg/mL)
in triplicate. Recovery (%) was calculated by the follow-
ing this equation: recovery (A) = (found amount – original
amount)/spiked amount × 100.18
2.2.  Cell-based  assay
2.2.1.  Chemicals  and  reagents
Dulbecco’s modiﬁed Eagle’s medium was obtained from
Lonza (Walkersville, MD, USA). Fetal bovine serum, peni-
cillin, streptomycin, and peroxidase-conjugated secondary
antibodies were purchased from Hyclone (Logan, UT, USA).
Propidium iodide (PI) and 3-(4,5-dimethylthiazol-2-ly)-2,5-
diphenyl-tetrazolium bromide (MTT) were purchased from
Sigma Chemical Co. (St. Louis, MO, USA). Caspase-Glo 3/7,
caspase-8, and caspase-9 assay kits were purchased from
Promega (Madison, WI,  USA). For immunoblotting, caspase-
3, caspase-8, caspase-9, poly (ADP-ribose) polymerase (PARP),
extracellular signal-regulated kinase (ERK), phospho-ERK, p38,
phospho-p38, c-Jun NH2-terminal kinase (JNK), phospho-JNK,
-tubulin, and glyceraldehyde 3-phosphate dehydrogenasellagic acid; and 6, PGG.
(GAPDH) were purchased from Cell Signal Technology, Inc.
(Boston, MA, USA).
2.2.2.  Cell  culture
Various human cancer cell lines, obtained from the Korean
Cell Line Bank (Seoul, Korea) and American Type Culture
Collection (Rockville, MD, USA), were cultured in Dulbecco’s
modiﬁed Eagle’s medium with 10% fetal bovine serum con-
taining 100 units/mL penicillin G and 100 g/mL streptomycin.
All cells were cultured in an atmosphere of 5% CO2 at 37 ◦C.
2.2.3.  Cell  viability  assay
Cells (3–5 × 103 cells/well) were seeded in a 96-well plate
and treated with various concentrations of GRE or AGRE for
24 hours. After treatment, cell viability was analyzed by MTT
assay as described previously.19 Color intensity was measured
in terms of absorbance at 570 nm with an enzyme-linked
immunosorbent assay (ELISA) microplate reader (Sunrise;
TECAN, Männedorf, Switzerland).
2.2.4.  Cell  cycle  analysis
Cells were seeded at a density of 1 × 105 cells/mL in a six-
well plate and treated with 50 g/mL and 100 g/mL of GRE
or AGRE for 24 hours. The PI staining for cell cycle analysis
19was performed as described previously. DNA contents of the
stained cells were analyzed by FACSCalibur ﬂow cytometry
using CellQuest software (Becton–Dickinson, Franklin Lakes,
NJ, USA).
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Table 1 – Linear regression date, LOD, and LOQ of investigated compounds from Galla Rhois
Analytes Linear regression data LODb (g/mL) LOQc (g/mL)
Linear range (g/mL) r2 Regressive equationa
Gallic acid 0.5–1000 1.0000 y = 186,801x – 145,236 0.05 0.15
Methyl gallate 0.20–100 0.9999 y  = 215,623x + 153,590 0.04 0.13
Digallic acid 0.5–100 0.9995 y  = 107,350x – 133,444 0.09 0.26
Syringic acid 0.5–100 0.9994 y = 143,259x – 132,447 0.06 0.19
Ellagic acid 0.5–100 1.0000 y = 119,577x – 411,970 0.08 0.23
PGG 0.2–100 0.9997 y = 203,960x – 379,570 0.04 0.13
a Here, y = peak area (mAU) and x = concentration (g/mL) of the components.
b LOD = 3 × signal-to-noise ratio.
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LOD, limit of detection; LOQ, limit of quantiﬁcation.
.2.5.  Western  blot  analysis
he cell lysates treated with GRE or AGRE for Western blot
nalysis were prepared as described previously.19 The same
mount of protein for each sample was electrophoresed and
ransferred onto the polyvinylidene diﬂuoride membrane Mil-
ipore (Millipore, Billerica, MA,  USA). The membranes were
ncubated at 4 ◦C overnight with primary antibodies speciﬁc
or caspase-3, caspase-8, caspase-9, PARP, ERK, phospho-ERK,
38, phospho-p38, JNK, phospho-JNK, -tubulin, and GAPDH
1:1000), followed by incubation for 1 hour with the corre-
ponding secondary antibody (1:5,000). Speciﬁc proteins were
etected using a Supersignal West Pico Chemiluminescent
ubstrate (Pierce, Rockford, IL, USA) and an ImageQuant LAS
000 mini (GE Healthcare, Piscataway, NJ, USA). Band intensi-
ies were calculated using ImageJ software (National Institute
f Health, Bethesda, MD, USA)..2.6.  Statistical  analysis
ata were presented as means ± SD. The statistically signif-
cant differences between control and botulin-treated cells
Table 2 – Repeatability (n = 3) and recoveries of investigated com
Peak Analytes Spiked amount
(g/mL)
Measured
(g/
1 Gallic acid
1,402.10  1,402.21
701.05 701.14
350.52 350.32
2 Methyl gallate
124.65  124.52
62.32 62.12
31.16 31.04
3 Digallic acid
302.55  302.38
151.27 151.27
75.63 75.54
4 Syringic acid
18.73  18.53
9.36 9.11
4.68 4.71
5 Ellagic acid
27.78  27.75
13.89 13.71
6.95 6.89
6 PGG
165.90 165.98
82.95 82.90
41.47 41.35were calculated by the Student t test. Values of p < 0.05 and
p < 0.01 were considered to indicate statistical signiﬁcance.
3.  Results
3.1.  Validation  of  quantitative  methods
The results of linearity, limit of detection, and limit of
quantiﬁcation analyses for each key analyte are summa-
rized in Table 1. Good linearity of the analytical method
was conﬁrmed by correlation coefﬁcients (r2 > 0.9994). Limit of
detection and limit of quantiﬁcation values were in the range
of 0.04–0.09 g/mL and 0.13–0.26 g/mL, respectively. RSD val-
ues for inter- and intraday variation were within the range of
0.51–1.47% and 0.84–2.57%, respectively. The value of RSD was
less than 3%, and these results showed an acceptable preci-
sion. The recovery ratio of the six standard compounds ranged
from 99% to 104% (Table 2). These results indicated that the
developed method had reliable accuracy.
pounds from Galla Rhois
 amount
mL)
Recovery
(%)
Interday
(RSD %)
Intraday
(RSD %)
 ± 0.20 99 0.87 1.75
 ± 0.10 100 1.01 1.89
 ± 0.20 100 0.45 0.84
 ± 0.20 102 1.42 2.74
 ± 0.20 100 1.20 1.97
 ± 0.10 104 0.81 2.07
 ± 0.10 101 0.51 1.42
 ± 0.01 99 0.78 1.84
 ± 0.20 99 1.11 1.40
 ± 0.20 100 1.45 2.14
 ± 0.20 102 1.34 1.85
 ± 0.10 99 1.47 2.57
 ± 0.10 100 0.84 1.57
 ± 0.20 99 1.42 1.84
 ± 0.10 100 0.95 1.01
 ± 0.05 101 1.41 2.48
 ± 0.05 100 1.24 2.21
 ± 0.10 101 1.36 1.64
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3.2.  Change  in  chemical  properties  of  GRE  following
the steaming  process
In the present study, HPLC was used to analyze the six compo-
nents present in GRE and AGRE using optimized HPLC–diode
array UV/VIS detector chromatographic conditions. The six
components, including gallic acid, methyl gallate, digallic
acid, syringic acid, ellagic acid, and PGG, were detected at
270 nm based on the stability and higher maximum absorp-
tion rates of the major components at baseline (268 nm for
gallic acid, 269 nm for methyl gallate, 275 nm for digallic
acid, 273 nm for syringic acid, 253 nm for ellagic acid, and
277 nm for PGG; Fig. 1A, 1B). The retention time of gallic
acid, methyl gallate, digallic acid, syringic acid, ellagic acid,
and PGG were 7.65 minutes, 30.01 minutes, 41.06 minutes,
49.33 minutes, 88.72 minutes, and 93.08 minutes, respectively.
In the present study, Contents of the six components in
GRE and AGRE were quantiﬁed using UV and mass spec-
troscopy spectra, and their retention times were compared
with those of standards using an optimized method. The
quantitative analysis data are shown in Fig. 1C. The contents
of gallic acid (123.3%) and ellagic acid (196.6%) in AGRE were
higher than the contents in GRE (100%). In contrast, methyl
gallate (1.4%), digallic acid (4.2%), syringic acid (18.5%), and
PGG (2.5%) were less presented in AGRE compared with GRE
(100%).
Fig. 2 – Inhibition of cell viability by GRE or AGRE in several hum
100 g/mL, and 200 g/mL of GRE or AGRE for 24 hours. Cell viab
expressed as the percentages of viable cells compared with thos
of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0
###p < 0.001 versus GRE-treated cells. *p < 0.05, **p < 0.01, and ***p <
###p < 0.001 versus GRE-treated cells. (B) Cells were  treated with t
AGRE for 24 hours in two kinds of human colon cancer cells, HCT
acid; 2, methyl gallate; 3, digallic acid; 4, syringic acid; 5, ellagic 
assay and the results are expressed as the percentages of viable
the means ± SD of three independent experiments. *p < 0.05, **p <
shown as the means ± SD of three independent experiments.Integr Med Res ( 2 0 1 6 ) 284–292
3.3.  Inhibition  of  cell  growth  by  GRE  and  AGRE  in
various  human  cancer  cells
To further characterize the inhibitory actions of GRE and AGRE
against cancer cells, ﬁve different human cancer cell lines
[HCT116 (colon), AGS (stomach), MM231 (breast), A549 (lung),
and SK-Hep-1 (liver)] were treated with 50 g/mL, 100 g/mL,
and 200 g/mL of GRE or AGRE for 24 hours. The viability of
HCT116, A549, and SK-Hep-1 cells was inhibited by over 60%
by treatment with 100 g/mL and 200 g/mL of GRE or AGRE
(Fig. 2A). The viability of HCT116 cells was reduced by about
50% and 64% by treating with 100 g/mL and 200 g/mL of GRE,
respectively. The viability was reduced by approximately 75%
and 80% by AGRE at the same concentrations. Additionally, the
growth inhibitory effect of AGRE on HCT116 cells was signiﬁ-
cantly greater than that of GRE. To further deﬁne the inhibitory
action of GRE and AGRE on colon cancer cells, the inhibition
ratios of each constituent in GRE and AGRE against two colon
cancer cell lines, HCT116 and HT29, were evaluated. In HCT116
cells, except digallic acid, the other constituents, including
gallic acid, methyl gallate, syringic acid, ellagic acid, and PGG,
inhibited cell growth in a dose-dependent manner for 24 hours
(Fig. 2B). In contrast, the viability of HT29 cells was affected
by about 40% by ellagic acid (from 12.5 M to 100 M). Based
on these data, the present study focused on HCT116 cells for
subsequent tests.
an cancer cells. (A) Cells were  treated with 50 g/mL,
ility was determined by MTT  assay, and the results are
e of untreated cells. The data are shown as the means ± SD
.001 versus untreated cells. #p < 0.05, ##p < 0.01, and
 0.001 versus untreated cells. #p < 0.05, ##p < 0.01, and
he indicated concentrations of six components in GRE and
116 and HT29. Six components are as follows: 1, gallic
acid; and 6, PGG. Cell viability was determined by MTT
 cells compared to untreated cells. The data are shown as
 0.01, and ***p < 0.001 versus untreated cells. The data are
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.4.  Comparison  of  cell  cycle  progression  in  HCT116
ells between  GRE  and  AGRE
fter treatment with GRE or AGRE for 24 hours, HCT116
ells were stained with PI, and their cell cycle progression
as assessed using ﬂow cytometry. Treatment of cells with
0 g/mL and 100 g/mL of GRE induced the cell population of
ub-G1 phase up to 2.90% and 6.65%, respectively (Fig. 3A).
GRE also induced the cell population of sub-G1 phase to
bout 5.06% and 11.73% at the same concentrations. In the S
hase, 100 g/mL of GRE induced the accumulation of 16.22%
f cells, which increased about 1.4-fold compared with that
n untreated cells (vehicle, 11.44%). Compared with the vehi-
le, treatment with 100 g/mL of AGRE slightly reduced the
-phase cell population in the S phase. However, 100 g/mL
f AGRE induced a 4.5-fold increase in the sub-G1 cell popula-
ion, which enhanced the induction of cell death about 1.8-fold
ompared with that observed with GRE (Fig. 3B).
.5.  Inhibitory  effect  of  GRE  and  AGRE  on  HCT116  cell
rowth
o determine whether the cell death by GRE and AGRE
s related to the apoptotic effects in HCT116 cells, the
ig. 3 – Effects of GRE and AGRE on cell cycle progression in HCT1
f GRE or AGRE for 24 hours, ﬁxed with prechilled 70% ethanol, s
o ﬂow cytometry for determination of cell cycle distribution. (B) hois in Human Colon Cancer Cells 289
expression of caspase activities, including activities of
caspase-3, caspase-8, and caspase-9, was assessed using
Western blot analysis. After 24 hours of treatment with GRE,
the caspases were activated and PARP cleavage was observed
in HCT116 cells (Fig. 4A). Almost all the caspases were acti-
vated by treatment with 100 g/mL of GRE. In particular, the
expression of caspase-3 and caspase-9 showed increases of
about 1.81- and 1.83-fold, respectively, compared with those
in untreated cells. In contrast, AGRE showed activation of cas-
pases at 50 g/mL concentration for the same duration. AGRE
also markedly increased PARP cleavage in a dose-dependent
manner. In comparison with GRE, AGRE showed over two-fold
increase in the expression of caspase-8, while the expression
of caspase-3 or caspase-9 was not affected or weakly upregu-
lated (Fig. 4B).
To identify the antiproliferative effects of GRE and AGRE
in HCT116 cells, expressions of cell proliferation-mediated
proteins were analyzed by Western blotting. The level of
phosphorylated JNK was decreased by about 19% by treat-
ing with 100 g/mL of GRE, but that of ERK and p38 at the
same concentration remained unaffected (Fig. 4C). In contrast,
100 g/mL of AGRE inhibited the phosphorylation of ERK and
JNK by about 30% and 67%, respectively; notably, the phos-
phorylation of p38 remained unaffected. Compared with GRE,
16 cells. (A) Cells were  treated with 50 g/mL and 100 g/mL
tained with propidium iodide solution, and then subjected
Histogram represents cell cycle analysis on HCT116 cells.
290  Integr Med Res ( 2 0 1 6 ) 284–292
Fig. 4 – Comparison of anticancer effects between GRE and AGRE on protein levels in HCT116 cells. (A) Induction of
apoptosis by GRE or AGRE in HCT116 cells. The cells were  exposed to 50 g/mL and 100 g/mL of GRE or AGRE for 24 hours;
protein levels were  determined by Western blot analyses. The band intensity was calculated and compared with that of
untreated cells using ImageJ after normalization relative to GAPDH expression. (B) Histogram represents the fold changes of
activated caspase-3, caspase-8, and caspase-9 by AGRE compared with that of GRE. (C) Antiproliferative effects of GRE and
AGRE on HCT116 cells. The cells were  exposed to 50 g/mL and 100 g/mL of GRE or AGRE for 24 hours, and then subjected
to Western blot analyses to determine the levels of phosphorylated forms of MAPK proteins, including ERK, p38, and JNK (or
AKT). (D) Investigation of the antiproliferative effects of GRE and AGRE for 24 hours using the MAPK cascade inhibitors
PD98059 (10 M), SB203580 (5 M),  and SP600125 (10 M),  and the PI3K inhibitor LY294005 (10 M).  Cell viability was
determined by MTT  assay. The results show the means ± SD of three independent experiments. *p < 0.05 and **p < 0.01
versus GRE treated cells.AGRE (100 g/mL) suppressed the phosphorylation of JNK by
approximately two-fold. At 50 g/mL concentrations, GRE and
AGRE strongly inhibited AKT phosphorylation by over 40%.
Furthermore, at 100 g/mL concentrations, AGRE suppressed
the phosphorylation of AKT by approximately two-fold
more than that of GRE. To conﬁrm the antiproliferation
effects of GRE and AGRE on A549 cells, the cells were pre-
treated with speciﬁc inhibitors, such as PD98059 (ERK1/2
inhibitor), SB203580 (p38 inhibitor), SP600125 (JNK inhibitor),
and LY294002 for 1 hour, followed by treatment with 100 g/mL
of GRE and AGRE for 24 hours. The antiproliferation effect of
GRE was increased in LY294002 by about 9%, whereas it did not
increase in the other inhibitors such as PD98059, SB203580,
and SP600125. Under the same conditions, pretreatment with
inhibitors, such as PD98059, SP600125, and LY294002, fol-
lowed by AGRE treatment markedly enhanced cell death.
SP600125 and LY294002 improved the antiproliferation effect
of AGRE up to 19% and 20%, respectively, whereas SB203580
weakly improved the antiproliferation effect by about 7%
(Fig. 4D).4.  Discussion
GR has resulted in the characterization of gallotannins, which
have been considered to possess medicinal properties and
numerous beneﬁts.20,21 Among the constituents of GR, gal-
lotannins are a type of hydrolyzable tannin consisting of a
central glucose core, surrounded by several gallic acid units
attached by depside bonding of additional galloyl residues.22,23
Furthermore, GR is rich in well-known phenolic acids, such
as gallic acid and methyl gallate that account for nearly
20% and 7%,  respectively.10,24 Based on these preliminary
reports, we investigated the changes in the constituents and
biological activities of GRE when physical heat was applied
using the steaming process at high temperature and pres-
sure with an autoclaved system. In the processing of speciﬁc
herbal medications, steaming treatment has been applied
to enhance the desirable effects and reduce the side effects
by changing the chemical constituents. Steaming of gin-
seng at 120 ◦C produced ginsenosides F4, Rg3, and Rg5, not
present in raw ginseng, and they were evaluated for their
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content. Korean J Orient Med Prescrip 2010;18:145–54 [In.-H. Yim et al/Enhancement of Anti-cancer Effect of Water Extract of G
nticancer effects.25,26 Through the steaming process, rhubarb
howed an increase in monoanthrone compounds such as
nthraquinones and a decrease in dianthrone compounds
uch as sennosides, which enhanced its antimicrobial and
nti-inﬂammatory effects.2 Furthermore, heat-treated licorice
ncreased the total polyphenol content, which is involved in
ntioxidant activity.3 Here, the processing of GRE generated a
ifferent chemical proﬁle compared with the nonprocessed
RE. The components that structurally changed following
he processing include gallic acid, ellagic acid, and PGG.
everal in vitro and in vivo studies have shown that gal-
ic acid, a typical phenolic acid, possesses antioxidant and
adical scavenging activities that are involved in exerting
nticancer effects.27 Ellagic acid is a hydrolyzable tannin con-
tituted polymers of gallic acid, linked to glucose centers to
orm the class of compounds known as ellagitannins.28 It
lso possesses potent anticarcinogenic/antimutagenic proper-
ies against a variety of carcinogens, including nitrosamines,
zoxymethane, and mycotoxins, and a strong antioxidant
ctivity.29,30 In previous reports, it has been demonstrated that
llagic acid protects hepatocytes from damage by reactive oxy-
en species.30 In addition, it has been reported that ellagic acid
xerts potent preventive and therapeutic effects against sev-
ral types of cancers, including colon, breast, prostate, skin,
nd esophageal cancers, and osteogenic sarcoma.31 It selec-
ively induces reactive oxygen species-mediated apoptosis
n cancerous B lymphocytes of patients with chronic lym-
hocytic leukemia.28 The present results demonstrated that
allic acid and ellagic acid were markedly increased in AGRE
ompared with GRE. These constituents strongly induced cell
eath in human colon cancer cells, suggesting that AGRE
ay show an increased radical scavenging effect, and these
ffects may affect cell death, which may enhance apopto-
is in HCT116 cells. Notably, in vitro studies have shown that
RE containing PGG inhibits tumor growth through the sup-
ression of angiogenesis and metastasis of cancer cells.32,33
n AGRE, the contents of PGG were signiﬁcantly reduced by
rocessing, which may also be involved in the increase of
alloyl residues such as gallic acid and ellagic acid. The charac-
eristic anticancer effect of PGG, for instance, antiangiogenic
r antimetastatic activity, was not identiﬁed in GRE and AGRE.
herefore, further studies are necessary to establish whether
GRE enhances the anticancer effect of GRE against angiogen-
sis and metastasis.
Based on these preliminary observations, molecular mech-
nisms underlying the anticarcinogenic effects of AGRE were
ssessed in HCT cells. Using Western blot analyses, AGRE
as shown to inﬂuence the expression levels of caspase-8,
aspase-9, and caspase-3. The caspase cascades are divided
nto two major pathways: an extrinsic pathway containing
aspase-8 and caspase-10, which is initiated by the ligand-
ediated activation of cell surface death receptors, and an
ntrinsic pathway containing caspase-9, which is activated
y intracellular signals from the mitochondria.34,35 In the
resent study, compared with GRE, AGRE markedly acti-
ated caspase-8 and caspase-9, although the activation of
aspase-3 was weakly induced. This suggests that AGRE
ed to strong apoptosis via a caspase-dependent pathway,
hich may enhance the anticancer effect of GRE in HCT116
ells.hois in Human Colon Cancer Cells 291
MAPKs regulate cellular processes such as proliferation,
differentiation, and apoptosis of cells.36 In particular, pharma-
cological modulation of MAPK signals inﬂuences the apoptotic
response to antitumor agents.37 The present results demon-
strated that AGRE inhibits the activation of ERK and JNK,
while p38 remained unaffected. GRE did not affect the sig-
nals of MAPK cascades, including ERK, JNK, and p38, involved
in inducing apoptosis in HCT116 cells. Additionally, the inhi-
bition of MAPK signaling by treatment of speciﬁc protein
inhibitors (ERK inhibitor PD98059, p38 inhibitor SB203580, and
JNK inhibitor SP600125) improved the cell death of AGRE,
whereas these inhibitors did not contribute to the apop-
totic function of GRE in HCT116 cells. Phosphorylation of
AKT, a cell survival-related protein, was strongly inhibited
by both GRE and AGRE, which conﬁrmed that the inhibition
of AKT improves cell death in HCT116 by GRE and AGRE
using treatment with LY294002. Therefore, we  suggest that
the antiproliferative activity of AGRE results from suppress-
ing the MAPK and AKT signaling pathways, whereas that of
GRE results from inhibiting AKT activation only.
We elucidated the enhancement of anticancer effect of
AGRE by steaming processing of GRE using the analysis of
chemical proﬁling and molecular mechanism study in human
colon cancer cells HCT116. The enhanced apoptotic effect of
AGRE was presumed to be attributed to the changes in the
pattern of gallotannins in GRE. In the case of molecular sig-
nals associated with cell proliferation, AGRE showed different
signals compared with GRE, which demonstrated a strong
antiproliferation effect in HCT116 cells. These results would
support the fact that the steaming process may be a feasible
method for improving the anticancer effects of GRE.
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